The improvement of sulforaphane in type 2 diabetes mellitus (T2DM) and related complications: A review-Reference-Cited by-同舟云学术

The improvement of sulforaphane in type 2 diabetes mellitus (T2DM) and related complications: A review

Published:2022-11 Issue: Volume:129 Page:397-407
ISSN:0924-2244
Container-title:Trends in Food Science & Technology
language:en
Short-container-title:Trends in Food Science & Technology

Author:

Wang Mengjiao^ORCID,Chen Min,Guo Rui,Ding Yangyang,Zhang Haihui,He Yuanqing^ORCID

Publisher

Elsevier BV

Subject

Food Science,Biotechnology

Reference97 articles.

1. Diet rich in high glucoraphanin broccoli reduces plasma LDL cholesterol: Evidence from randomised controlled trials;Armah;Molecular Nutrition & Food Research,2015

2. A diet rich in high-glucoraphanin broccoli interacts with genotype to reduce discordance in plasma metabolite profiles by modulating mitochondrial function;Armah;American Journal of Clinical Nutrition,2013

3. Sulforaphane reduces hepatic glucose production and improves glucose control in patients with type 2 diabetes;Axelsson;Science Translational Medicine,2017

4. Type 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional intervention;Badawi;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy,2010

5. Broccoli sprouts reduce oxidative stress in type 2 diabetes: A randomized double-blind clinical trial;Bahadoran;European Journal of Clinical Nutrition,2011

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypoglycemic Effect of Polysaccharides from Physalis alkekengi L. in Type 2 Diabetes Mellitus Mice;Biology;2024-07-04

2. Network Pharmacology Analysis, Molecular Docking Integrated Experimental Verification Reveal the Mechanism of Gynostemma pentaphyllum in the Treatment of Type II Diabetes by Regulating the IRS1/PI3K/Akt Signaling Pathway;Current Issues in Molecular Biology;2024-06-01

3. Immunotherapy targeting the obese white adipose tissue microenvironment: Focus on non-communicable diseases;Bioactive Materials;2024-05

4. Gut microbiota and host metabolizing enzymes co‐contribute to pharmacokinetic variability in type 2 diabetes mellitus rats;eFood;2024-02-20

5. Sulforaphane—A Compound with Potential Health Benefits for Disease Prevention and Treatment: Insights from Pharmacological and Toxicological Experimental Studies;Antioxidants;2024-01-25